| Secondary |
| Crohn's Disease |
23.3% |
| Product Used For Unknown Indication |
13.3% |
| Chronic Obstructive Pulmonary Disease |
10.0% |
| Rheumatoid Arthritis |
10.0% |
| Analgesic Therapy |
6.7% |
| Polyarthritis |
6.7% |
| Autoimmune Thrombocytopenia |
3.3% |
| Diabetes Mellitus |
3.3% |
| Drug Use For Unknown Indication |
3.3% |
| Epilepsy |
3.3% |
| Hiv Infection |
3.3% |
| Hypertension |
3.3% |
| Ovarian Neoplasm |
3.3% |
| Psoriasis |
3.3% |
| Sedation |
3.3% |
|
| Myositis |
23.1% |
| Reversible Posterior Leukoencephalopathy Syndrome |
15.4% |
| Thrombocytopenia |
15.4% |
| Alopecia |
7.7% |
| Diabetes Mellitus |
7.7% |
| Neuromyopathy |
7.7% |
| Treatment Failure |
7.7% |
| Weight Increased |
7.7% |
| Wound |
7.7% |
|
| Concomitant |
| Rheumatoid Arthritis |
29.2% |
| Drug Use For Unknown Indication |
15.3% |
| Product Used For Unknown Indication |
10.2% |
| Pain |
7.8% |
| Hypertension |
4.8% |
| Chronic Obstructive Pulmonary Disease |
3.2% |
| Gastric Disorder |
3.0% |
| Respiratory Distress |
2.8% |
| Asthma |
2.6% |
| Bone Marrow Transplant |
2.6% |
| Infection |
2.6% |
| Premedication |
2.6% |
| Acute Lymphocytic Leukaemia |
2.4% |
| Relapsing-remitting Multiple Sclerosis |
1.9% |
| Nausea |
1.7% |
| Ovarian Cancer |
1.7% |
| Crohn's Disease |
1.5% |
| Depression |
1.5% |
| Anxiety |
1.3% |
| H1n1 Influenza |
1.3% |
|
| Tuberculosis |
10.0% |
| Spinal Decompression |
8.3% |
| Fatigue |
6.7% |
| Lung Adenocarcinoma |
6.7% |
| Fall |
5.0% |
| Gamma-glutamyltransferase Increased |
5.0% |
| Pyrexia |
5.0% |
| Rash |
5.0% |
| Syncope |
5.0% |
| Tachypnoea |
5.0% |
| Tinnitus |
5.0% |
| Vision Blurred |
5.0% |
| Weight Increased |
5.0% |
| Breast Cancer |
3.3% |
| Breast Cancer Stage I |
3.3% |
| Hypertension |
3.3% |
| Leukaemoid Reaction |
3.3% |
| Lung Neoplasm Malignant |
3.3% |
| Myalgia |
3.3% |
| Mycosis Fungoides |
3.3% |
|
| Interacting |
| Convulsion |
25.0% |
| Drug Use For Unknown Indication |
25.0% |
| Rheumatoid Arthritis |
25.0% |
| Systemic Lupus Erythematosus |
25.0% |
|
| Systemic Lupus Erythematosus |
100.0% |
|
